Methodological mimesis and the value of pharmaceutical failures
Recent controversies over the safety of drugs such as Vioxx, a painkiller manufactured by Merck, and Seroxat, an SSRI antidepressant manufactured by GlaxoSmithKline, have led to a consequence that at first seems entirely positive: they have attracted more attention to the suppression of negative cli...
Päätekijä: | McGoey, L |
---|---|
Aineistotyyppi: | Conference item |
Julkaistu: |
2009
|
Samankaltaisia teoksia
-
Pharmaceutical Controversies and the Performative Value of Uncertainty
Tekijä: McGoey, L
Julkaistu: (2009) -
Pharmaceutical Hope
Tekijä: McGoey, L
Julkaistu: (2007) -
Profitable failure: antidepressant drugs and the triumph of flawed experiments
Tekijä: McGoey, L
Julkaistu: (2010) -
Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
Tekijä: McGoey, L, et al.
Julkaistu: (2008) -
Sequestered Evidence and the Distortion of Clinical Practice Guidelines
Tekijä: McGoey, L
Julkaistu: (2009)